ストックスクリーナーアプリを入手
116.80
4.32%
-5.27
アフターアワーズ：
116.80
Veradermics Inc (MANE) 最新ニュース
Hair loss biotech Veradermics, up 656% since its IPO, credits the obesity boom - BioSpace
Veradermics, Incorporated(NYSE: MANE) added to Russell 2000 Index - marketscreener.com
Veradermics, Incorporated(NYSE: MANE) added to Russell 2000 Value Benchmark - marketscreener.com
Veradermics, Incorporated(NYSE: MANE) added to Russell 2000 Growth Benchmark - marketscreener.com
Veradermics, Incorporated(NYSE: MANE) added to Russell 3000E Growth Benchmark - marketscreener.com
2026 Power 25 Healthcare: Dr. Reid Waldman - Hartford Business Journal
Veradermics, Incorporated(NYSE: MANE) added to Russell Small Cap Completeness Index - marketscreener.com
Veradermics, Incorporated(NYSE: MANE) added to Russell 3000E Index - marketscreener.com
Veradermics, Incorporated Actuals & Estimates (NYSE:MANE) - TradingView
Cantor Fitzgerald reiterates Veradermics stock rating after CEO dinner By Investing.com - Investing.com Australia
MANE Forecast — Price Target — Prediction for 2027 - TradingView
Cantor Fitzgerald reiterates Veradermics stock rating after CEO dinner - Investing.com
MANE Stock Pops As Traders Hunt Biotech Momentum - StocksToTrade
Can Veradermics (MANE) Climb 27.65% to Reach the Level Wall Street Analysts Expect? - Yahoo Finance
Citi Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $135 - Moomoo
Veradermics, Incorporated(NYSE: MANE) added to S&P Global BMI Index - marketscreener.com
Veradermics, Incorporated(NYSE:MANE) added to S&P Pharmaceuticals Select Industry Index - marketscreener.com
Is Veradermics, Incorporated (MANE) A Good Stock To Buy Now? - Yahoo Finance
MANEVeradermics Inc Forecast, Target Price - Finviz
Veradermics Incorporated (MANE) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
BHVN,MANE Forecast, Target Price - Finviz
Analysts Offer Insights on NA Companies: Sunbelt Rentals Holdings Inc (SUNB), Veradermics, Incorporated (MANE) and JBS (JBS) - The Globe and Mail
Jefferies Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $138 - Moomoo
LifeSci Capital Initiates Veradermics(MANE.US) With Buy Rating, Announces Target Price $135 - Moomoo
Veradermics Company Profile & Introduction - Moomoo
MANE: Extended-release oral minoxidil shows promise for rapid, consistent hair growth in large, underserved markets - TradingView
Total liabilities of Veradermics, Incorporated – BX:MANE - TradingView
Number of shareholders of Veradermics, Incorporated – BX:MANE - TradingView
MANE Technical Analysis | Trend, Signals & Chart Patterns | VERADERMICS INC (NYSE:MANE) - ChartMill
Hot Picks: Biotech rebound driven by innovation and drug pipelines - BNN Bloomberg
Veradermics (MANE) Jefferies Global Healthcare Conference 2026 Summary - Quartr
Needham Initiates Veradermics(MANE.US) With Buy Rating, Announces Target Price $136 - Moomoo
Two biotech leaders join Achieve Life's new quitting drug push - Stock Titan
This New Hair-Loss Drug Could Be the Biggest Breakthrough in Decades - Cosmopolitan
Veradermics to Present at Upcoming June 2026 Investor Conferences - BioSpace
Veradermics to Present at Upcoming June Investor Conferences - Business Wire
Veradermics to Present VDPHL01 Phase 2/3 ‘302’ Study Results at 2026 World Congress for Hair Research - geneonline.com
Veradermics Announces Poster Presentation on Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 at the 2026 World Congress for Hair Research - BioSpace
Veradermics to present hair loss drug trial data on Friday - Investing.com
Veradermics to present hair loss drug trial data on Friday By Investing.com - Investing.com Canada
New oral drug shows success in reversing hair loss - Fast Company
10 Best Performing NYSE Stocks So Far in 2026 - Insider Monkey
Viking Stake In Veradermics Highlights Risky Growth And Ownership Shifts - Yahoo Finance
Here is Why Veradermics (MANE) is One of the Best Performing NYSE Stocks So Far in 2026 - Insider Monkey
Veradermics Is Maintained at Buy by Citigroup - Moomoo
Veradermics Price Target Raised to $135.00/Share From $120.00 by Citigroup - Moomoo
SR ONE CAPITAL MANAGEMENT, LP's Veradermics Inc(MANE) Holding History - GuruFocus
Citi Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $135 - Moomoo
Viking Global-affiliates hold 1.69M Veradermics shares (MANE) - Stock Titan
This Fund Has a $75 Million Bet on a Hair Loss Biotech Stock Up More Than 500% Post-IPO - Yahoo Finance
Jefferies Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $138 - Moomoo
Veradermics (MANE) price target increased by 39.48% to 128.52 - MSN
Veradermics Announces Two Poster Presentations on VDPHL01 at the 2026 Music City SCALE Symposium - Business Wire
Can Veradermics Rally on Clinical Progress in Biotech Index? - Kalkine Media
1.17%
2.48%
大文字化:
|
ボリューム (24 時間):